Our findings build upon prior work from our group and others that suggest insulin dysregulation exists peripherally and centrally in AD (Burns et al., 2007; Craft et al., 2012; Talbot et al., 2012; Morris et al., 2016a), and extends these findings to include additional metabolic-related hormones. This evidence concerns the gene INS and Alzheimer disease.